BP1136

Oxycodone impurity standard

British Pharmacopoeia (BP) Reference Standard

• UNSPSC Code: 41116107

Properties

• grade: pharmaceutical primary standard
• API family: oxycodone
• form: solid
• shelf life: limited shelf life, expiry date on the label
• manufacturer/tradename: BP
• drug control: estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
• application(s): pharmaceutical
• format: mixture
• storage temp.: 2-8°C

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Oxycodone impurity standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Oxycodone Capsules

Oxycodone Prolonged-release Tablets

Oxycodone Oral Solution

Oxycodone Injection

Packaging

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS06,GHS08
• Signal Word: Danger
• Hazard Statements: H300 + H310 + H330 - H336 - H340
• Precautionary Statements: P202 - P260 - P264 - P280 - P302 + P352 + P310 - P304 + P340 + P310
• Hazard Classifications: Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Muta. 1B - STOT SE 3
• Target Organs: Central nervous system
• Storage Class Code: 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials
• WGK: WGK 3